Joint IP and Science Subcommittee Meeting
MEETING NOTICE AND AGENDA
JOINT MEETING OF THE INTELLECTUAL PROPERTY & INDUSTRY AND SCIENCE SUBCOMMITTEES
OF THE INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE TO
THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant to the CALIFORNIA STEM CELL RESEARCH AND CURES ACT
Friday, April 8th, 2016
9:00am to 11:00am
- 1999 Harrison Street, Suite 1650, Oakland, CA 94162
- 1180 Veteran's Blvd, South San Francisco, 94080
- 2007 Redwood Rd, Napa, CA
- 837 Health Science Road Irvine, CA 92697-4292
- 2619 Montclair Street San Diego, CA 92104
- 747 52nd Street Oakland, CA 94609-1809
- 8700 Beverly Blvd 2015, Los Angeles, CA 90048
10901 North Torrey Pines Road La Jolla, CA 92037
Dial In Number:
- (800) 230-1074
[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]
- Call to Order.
- Roll Call.
- Consideration of Loan Terms for the Accelerating Therapies Through Public Private Partnership (ATP3) RFA.
ATP3 Term Sheet Memo
ATP3 Term Sheet
ATP3 Presentation (Updated)
- Public Comment
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.
The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9101 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at email@example.com or 510-340-9101.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov